Innovative Biotechnology Firm Kalohexis Launches Cutting-Edge Treatments for Obesity and Metabolic Disorders Kalohexis has emerged as a pioneering biotech firm, focused on developing first-class therapies targeting obesity and metabolic diseases through the melanocortin system.

Innovative Biotechnology Firm Kalohexis Launches Cutting-Edge Treatments for Obesity and Metabolic Disorders #USA #obesity #Northbrook #Melanocortin #Kalohexis

The winter olympic log with Milano Cortina replaced with melanocortin and the rings represented by melanocortin neurons

All I can think of when someone mentions the #olympics venue. #hypothalamus #melanocortin #pomc

Micrograph showing genetically labeled oxytocin-producing neurons (green fluorescence) in the paraventricular nucleus of the mouse hypothalamus. Credit: Pierre-Yves Barelle & Sebastien G Bouret.

The hypothalamic #melanocortin circuit is crucial for regulating energy balance, but how does it arise? @sebastienbouret.bsky.social &co show in mice that early postnatal activity & vesicle release from #oxytocin neurons are critical for proper circuit development @plosbiology.org 🧪 plos.io/49ifiKW

Micrograph showing genetically labeled oxytocin-producing neurons (green fluorescence) in the paraventricular nucleus of the mouse hypothalamus. Credit: Pierre-Yves Barelle & Sebastien G Bouret.

The hypothalamic #melanocortin circuit is crucial for regulating energy balance, but how does it arise? @sebastienbouret.bsky.social &co show in mice that early postnatal activity & vesicle release from #oxytocin neurons are critical for proper circuit development @plosbiology.org 🧪 plos.io/49ifiKW

The hypothalamic #melanocortin circuit is crucial for regulating energy balance, but how does it arise? @sebastienbouret.bsky.social &co show in mice that early postnatal activity & vesicle release from #oxytocin neurons are critical for proper circuit development @plosbiology.org 🧪 plos.io/49ifiKW

Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal diseases Boehringer and Palatin Technologies team up to develop potential first-in-class melanocortin receptor targeted treatment for patients with retinal...

Boehringer Ingelheim and Palatin Technologies to develop potential first-in-class #melanocortin receptor targeted treatment for patients with #retinal diseases

Total deal up to €280 million

www.globenewswire.com/news-release...

MCR Therapies Market Anticipates Rapid Growth by 2034 Driven by Innovations and New Indications The MCR therapies market is expected to witness significant growth by 2034. Innovations and new therapeutic indications are paving the way for broader acceptance and potential market expansion.

MCR Therapies Market Anticipates Rapid Growth by 2034 Driven by Innovations and New Indications #None #DelveInsight #Melanocortin #MCR_Therapies

Brain sensing of metabolic state regulates circulating monocytes Brain-initiated hunger signals control circulating monocyte dynamics.

Our latest study
@science.org #Immunology on perception of #hunger and #immunity.

#BrainBody #Melanocortin #AgRP #POMC neurons. #Brain-liver axis. Permissive action of #stress #hormones.

@ukri.org @fbmh-uom.bsky.social

www.science.org/doi/10.1126/...

Palatin Technologies Secures $3.4 Million from Warrant Exercise with New Investor Agreement Palatin Technologies enters into a significant investment agreement to exercise warrants, securing $3.4 million for future growth initiatives.

Palatin Technologies Secures $3.4 Million from Warrant Exercise with New Investor Agreement #USA #Palatin_Technologies #Cranbury #NYSE_PTN #Melanocortin

📢 ECR Scholarships are open!
The Journal of Neuroendocrinology is supporting 6 registration scholarships for ECRs 💸 to attend 7th International Melanocortin Meeting, 15-17 Sept 2025.

Apply by 4.4.25 melanocortinmeeting.org/scholarships/

#ECR #Melanocortin #Neuroendocrinology